OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO. Stock

Certificat

DE000GK9VV75

Real-time BOERSE MUENCHEN 10:27:21 2024-05-21 am EDT
6.06 EUR 0.00% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO.
Current month-4.42%
1 month-4.87%
Date Price Change
24-05-21 6.06 0.00%
24-05-20 6.06 -0.82%
24-05-17 6.11 +1.66%
24-05-16 6.01 +0.67%
24-05-15 5.97 -4.33%

Real-time BOERSE MUENCHEN

Last update May 21, 2024 at 10:27 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GK9VV7
ISINDE000GK9VV75
Date issued 2022-09-01
Strike 302.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.95
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.89
Lowest since issue 1.43
Spread 0.02
Spread %0.33%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
237.1 USD
Average target price
279 USD
Spread / Average Target
+17.66%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW